Published in Ann Surg on October 01, 1993
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes (1970) 3.12
A model of the kinetics of insulin in man. J Clin Invest (1974) 2.97
Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes (1987) 2.95
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45
A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med (1973) 2.33
Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest (1975) 2.09
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest (1975) 2.04
Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl (1985) 1.63
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med (1991) 1.32
Insulin suppresses its own secretion in vivo. Diabetes (1987) 1.31
Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol (1990) 1.29
Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab (1983) 1.21
An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest (1983) 1.20
Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes (1990) 1.17
Pancreatic endocrine responses to stimulation of the peripheral ends of the splanchnic nerves in the conscious adrenalectomized calf. J Physiol (1980) 1.13
Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. J Clin Invest (1978) 1.11
Innervation of the pancreas by neurons in the gut. J Neurosci (1990) 1.10
Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism (1987) 1.08
Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol (Copenh) (1983) 1.04
The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev (1987) 1.04
Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. Am J Physiol (1975) 1.04
Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes (1992) 1.01
Immunological and biological properties of iodoinsulin labeled with one or less atoms of iodine per molecule. J Clin Invest (1968) 0.99
Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. Acta Endocrinol (Copenh) (1981) 0.95
Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes (1990) 0.93
Metabolism of endogenous proinsulin and insulin in man. J Clin Endocrinol Metab (1974) 0.93
Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg (1992) 0.92
Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs. Diabetes (1984) 0.89
Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation. Diabetes (1989) 0.87
Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery. Diabetes (1990) 0.87
Glucose metabolism after pancreas autotransplantation. The effect of open duct versus urinary bladder drainage technique. Ann Surg (1991) 0.87
Assessment of glucose turnover rates in euglycaemic clamp studies using primed-constant [3-3H]-glucose infusion and labelled or unlabelled glucose infusates. Diabet Med (1992) 0.86
Peripheral insulin release after pancreatic resection: the effect of decreased beta-cell mass with systemic or portal drainage. Endocrinology (1988) 0.85
Islet cell responses to glucose in human transplanted pancreas. Am J Physiol (1991) 0.84
Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology (1990) 0.84
Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state. Am J Physiol (1992) 0.83
Influence of the vagus and splanchnic nerves on insulin secretion and glycemia. J Auton Nerv Syst (1979) 0.83
Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res (1961) 0.82
Splanchnic neural regulation of insulin and glucagon secretion in the isolated perfused human pancreas. Am J Surg (1987) 0.81
Relative hypersecretion of proinsulin in rat model of NIDDM. Diabetes (1991) 0.81
Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am J Physiol (1993) 0.79
Endocrine function of the heterotopic pancreatic allotransplant in dogs. Transplantation (1981) 0.78
Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes (1989) 0.77
The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog. Horm Metab Res (1985) 0.77
Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) (1991) 0.76
Laparoscopic cholecystectomy. Treatment of choice for symptomatic cholelithiasis. Ann Surg (1991) 3.11
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol (1986) 2.94
Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol (2000) 2.94
Salmonellae as an index of pollution of surface waters. Appl Microbiol (1972) 2.46
Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev (1998) 2.39
Saltation and stasis: a model of human growth. Science (1992) 2.28
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol (1993) 2.06
Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes (1983) 1.89
Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab (1991) 1.84
Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci U S A (1996) 1.79
Laparoscopic cholecystectomy in the obese patient. Ann Surg (1992) 1.74
Impact of age on weight goals. Ann Intern Med (1985) 1.73
Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. J Clin Endocrinol Metab (1995) 1.72
Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol (1996) 1.66
Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal. Endocr Rev (1980) 1.58
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab (1987) 1.58
An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab (1993) 1.56
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. Proc Natl Acad Sci U S A (2001) 1.55
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes (2001) 1.54
Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab (1998) 1.51
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur J Endocrinol (1997) 1.43
Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest (1994) 1.42
Synthetic somatostatin analog (octreotide) suppresses daytime growth hormone secretion equivalently in young and older men: preserved pituitary responsiveness to somatostatin's inhibition in aging. J Am Geriatr Soc (1999) 1.41
Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl (2007) 1.40
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A (1998) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest (1988) 1.36
Methods for revoval of the vitelline membrane of sea urchin eggs. I. Use of dithiothreitol (Cleland Reagent). Exp Cell Res (1970) 1.35
Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev (1988) 1.33
Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest (1986) 1.33
Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol (1989) 1.32
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab (1996) 1.31
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes (1998) 1.30
Outpatient laparoscopic cholecystectomy: patient outcomes after implementation of a clinical pathway. Ann Surg (2001) 1.28
Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle. J Clin Endocrinol Metab (1984) 1.27
Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab (2001) 1.26
Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab (1989) 1.26
Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med (1982) 1.24
Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord (2003) 1.24
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab (2011) 1.23
Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab (1987) 1.23
Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging (1997) 1.22
Surgical resection for benign and malignant liver disease. Ann Surg (1980) 1.22
Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab (1993) 1.22
Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest (1978) 1.22
Hormonal control of substrate cycling in humans. J Clin Invest (1988) 1.22
Hepatic resection for metastatic cancer. Ann Surg (1984) 1.21
Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest (1997) 1.20
Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol (1999) 1.20
Studies in the distribution of body fat. II. Longitudinal effects of change in weight. Int J Obes (1989) 1.18
Arp2/3 complex: advances on the inner workings of a molecular machine. Cell (2001) 1.16
Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene (2008) 1.16
Does waist circumference add to the predictive power of the body mass index for coronary risk? Obes Res (2001) 1.12
Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab (1998) 1.12
Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab (2002) 1.11
Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab (1985) 1.11
Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab (1994) 1.10
Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab (1993) 1.10
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab (1996) 1.10
Gastrointestinal complications after cardiopulmonary bypass. Surgery (1982) 1.10
Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol (1985) (1999) 1.09
Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). Diabetes (2000) 1.09
Protein discharge from immature secretory granules displays both regulated and constitutive characteristics. J Biol Chem (1991) 1.08
Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects. J Clin Endocrinol Metab (1998) 1.08
General surgical complications can be predicted after cardiopulmonary bypass. Ann Surg (1995) 1.07
Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. J Clin Endocrinol Metab (2001) 1.07
Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev (1992) 1.06
Exercise training at and above the lactate threshold in previously untrained women. Int J Sports Med (1992) 1.06
Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol (1991) 1.06
The effect of age on insulin resistance and secretion: a review. Semin Nephrol (1996) 1.05
Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res (1996) 1.05
Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab (1992) 1.05
A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab (2000) 1.04
Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg (2000) 1.04
Effect of insulin infusions on the glucose kinetics in alloxan-steptozotocin diabetic dogs. Diabetologia (1974) 1.02
Resistive training increases fat-free mass and maintains RMR despite weight loss in postmenopausal women. J Appl Physiol (1985) (1995) 1.02
Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg (1997) 1.02
Beta-1,3-glucanase of sea urchin eggs: release from particles at fertilization. Science (1969) 1.02
Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab (1993) 1.02
Appraising the nature of luteinizing hormone secretory events in men. Am J Physiol (1987) 1.01
Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg (1986) 1.01
Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology (2011) 1.01
Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol (1999) 1.00
A biomathematical model of time-delayed feedback in the human male hypothalamic-pituitary-Leydig cell axis. Am J Physiol (1998) 1.00
Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev (2001) 1.00
Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology (2000) 1.00
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab (1997) 1.00
The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes (1984) 0.99
Joint recovery of pulsatile and basal hormone secretion by stochastic nonlinear random-effects analysis. Am J Physiol (1998) 0.99
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) (1992) 0.98
Maturation of spontaneous and agonist-induced uterine contractions in the peripartum mouse uterus. Biol Reprod (1999) 0.98
Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab (1991) 0.98
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab (2001) 0.98